                         SEQUENCE LISTING

<110>  CEVEC Pharmaceuticals GmbH
 
<120>  Method for the Production of AAV

<130>  C 4995WO - kl

<150>  EP 20 209 811.7
<151>  25.11.2020

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Primer

<400>  1
agcaatagca tcacaaattt cacaa                                             25


<210>  2
<211>  29
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Primer

<400>  2
ccagacatga taagatacat tgatgagtt                                         29


<210>  3
<211>  36
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Probe

<400>  3
agcatttttt tcactgcatt ctagttgtgg tttgtc                                 36


<210>  4
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Primer

<400>  4
ttcttcaagt ccgccatgcc                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Primer

<400>  5
aagtcgatgc ccttcagctc                                                   20


<210>  6
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Probe

<400>  6
cgcaccatct tcttcaagga cgacggcaac taca                                   34


